← Leaderboards
Jenny T Mao
Va San Diego Healthcare System
$6,008,249
Attributed
$6,008,249
Total exposure
7
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.1M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,008,249 · 4
VA$0 · 3
By mechanism
U01$5,141,941 · 1
R21$611,968 · 2
K23$254,340 · 1
I01$0 · 3
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Clinical Trials”
- Lawrence Corey · Fred Hutchinson Cancer Center$824,102,536
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$622,583,125
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$542,008,718
- Bambra Strokes · Ppd Development Lp$526,656,217
- Judith S. Currier · University Of California Los Angeles$504,273,077
Research focus
Clinical TrialsFutureMonitorMalignant Neoplasm Of LungCancer EtiologyCessation Of LifeInsightLungPathway InteractionsPropertySurrogate EndpointSamplingMediatingA549Malignant NeoplasmsIndexingBiological MarkersPlasmaOralApoptosisHealth FoodAftercareInflammatory MarkerBiological Availability
Grant awards (29)
Combinations of Grape Seed and Milk Thistle Extracts Against Lung$0
I01 · FY2025 · VA · contact PI
Leucoselect Phytosome for Neoadjuvant Treatment of Early Stage Lung Cancer$0
I01 · FY2025 · VA · contact PI
Combinations of Grape Seed and Milk Thistle Extracts Against Lung$0
I01 · FY2024 · VA · contact PI
Leucoselect Phytosome for Neoadjuvant Treatment of Early Stage Lung Cancer$0
I01 · FY2024 · VA · contact PI
Leucoselect Phytosome for Neoadjuvant Treatment of Early Stage Lung Cancer$0
I01 · FY2023 · VA · contact PI
Combinations of Grape Seed and Milk Thistle Extracts Against Lung$0
I01 · FY2023 · VA · contact PI
Combinations of Grape Seed and Milk Thistle Extracts Against Lung$0
I01 · FY2022 · VA · contact PI
Leucoselect Phytosome for Neoadjuvant Treatment of Early Stage Lung Cancer$0
I01 · FY2022 · VA · contact PI
Leucoselect Phytosome for Neoadjuvant Treatment of Early Stage Lung Cancer$0
I01 · FY2022 · VA · contact PI
Leucoselect Phytosome for Neoadjuvant Treatment of Early Stage Lung Cancer$0
I01 · FY2021 · VA · contact PI
Combinations of Grape Seed and Milk Thistle Extracts Against Lung$0
I01 · FY2021 · VA · contact PI
Combinations of Grape Seed and Milk Thistle Extracts Against Lung$0
I01 · FY2020 · VA · contact PI
Combinations of Grape Seed and Milk Thistle Extracts Against Lung$0
I01 · FY2019 · VA · contact PI
The Effects of Grape Seed Extract Against Lung Cancer$0
I01 · FY2016 · VA · contact PI
Feasibility of grape seed extract for lung cancer chemoprevention$111,270
R21 · FY2015 · CA · contact PI
The Effects of Grape Seed Extract Against Lung Cancer$0
I01 · FY2015 · VA · contact PI
Feasibility of grape seed extract for lung cancer chemoprevention$26,283
R21 · FY2014 · CA · contact PI
The Effects of Grape Seed Extract Against Lung Cancer$0
I01 · FY2014 · VA · contact PI
Feasibility of grape seed extract for lung cancer chemoprevention$174,918
R21 · FY2013 · CA · contact PI
Anti-carcinogenic effects of White Tea on Lung Cancer$136,873
R21 · FY2010 · AT · contact PI
Anti-carcinogenic effects of White Tea on Lung Cancer$162,624
R21 · FY2009 · AT · contact PI
LUNG CANCER CHEMOPREVENTION WITH CELECOXIB IN EX-SMOKERS$502,200
U01 · FY2007 · CA · contact PI
LUNG CANCER CHEMOPREVENTION WITH CELECOXIB IN EX-SMOKERS$1,051,181
U01 · FY2006 · CA · contact PI
LUNG CANCER CHEMOPREVENTION WITH CELECOXIB IN EX-SMOKERS$1,051,799
U01 · FY2005 · CA
LUNG CANCER CHEMOPREVENTION WITH CELECOXIB IN EX-SMOKERS$523,113
U01 · FY2004 · CA
LUNG CANCER CHEMOPREVENTION WITH CELECOXIB IN EX-SMOKERS$1,004,570
U01 · FY2003 · CA
LUNG CANCER CHEMOPREVENTION WITH CELECOXIB IN EX-SMOKERS$1,009,078
U01 · FY2002 · CA
SURVEILLANCE AND CHEMOPREVENTION FOR SECOND LUNG CANCERS$127,170
K23 · FY2001 · CA
SURVEILLANCE AND CHEMOPREVENTION FOR SECOND LUNG CANCERS$127,170
K23 · FY2000 · CA